Sell Jubilant Life Sciences, target Rs 300: Microsec Capital
Sell Jubilant Life Sciences Ltd. at a price target of Rs 300 and a stop loss at Rs 30914-07-2016
14-07-2016
Exercise of ESOP Options
Jubilant Life Sciences Ltd has informed BSE that 78,746 options under JLL Employees Stock Option Plan 2011 (Plan 2011") have been exercised by one option holder.Pursuant to the terms of Plan 2011, the Nomination, Remuneration and Compensation Committee of the Company has approved transfer of 78,746 equity shares of Re. 1 each of Jubilant Life Sciences Limited from Jubilant Employees Welfare Trust to the said option holder.12-07-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
Jubilant Life Sciences Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.08-07-2016
What to buy, sell and hold
Prabhudas Lilladher has a buy rating on Jubilant Life Sciences but has decreased its target price to Rs 484. It said that with the steady Ebitda margin of 25-29% in Pharma.06-07-2016
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Jubilant Stock Holding Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE29-06-2016
Intimation of Schedule of Investor/Analyst meetings on June 29 and 30, 2016
Jubilant Life Sciences Ltd has informed BSE regarding "Intimation of Schedule of Investor/Analyst meetings on June 29 and 30, 2016".28-06-2016
Reasonable valuations make Jubilant Life Sciences stock analysts' favourite
A 65% y-o-y increase in net profit, approvals for new generic drug applications, reduction in debt, and resonable valuations have made the counter analysts' favourite.20-06-2016
Exercise of ESOP Options
Jubilant Life Sciences Ltd has informed BSE that 800 options under Jubilant Employees Stock Option Plan 2005 (Plan 2005") and 1,974 options under JLL Employees Stock Option Plan 2011 (Plan 2011) have been exercised by the option holders.Pursuant to the terms of Plan 2005 and Plan 2011, the Nomination, Remuneration and Compensation Committee of the Company (the Committee") has approved transfer of 5,974 equity shares of Re. 1 each of Jubilant...13-06-2016
Jubilant Life Sciences gains on USFDA approval for epilepsy treatment injection
The stock has rallied 6% to Rs 374 on the BSE in an early morning trade06-06-2016